Stay updated on SBRT and Virus Therapy Before Pembrolizumab in Cancer Clinical Trial
Sign up to get notified when there's something new on the SBRT and Virus Therapy Before Pembrolizumab in Cancer Clinical Trial page.

Latest updates to the SBRT and Virus Therapy Before Pembrolizumab in Cancer Clinical Trial page
- Check5 days agoChange DetectedRevision history updated to record the current version: added Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added and the government funding outage notice (Revision: v3.4.1) was removed; these are operational site updates that do not affect the trial details shown.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a government funding lapse notice and updated the page revision to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check48 days agoChange DetectedAdded a glossary display option and updated QC-related labels, with the page revision now listed as v3.4.0 replacing the previous version; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedPage shows a new revision indicator: 'Revision: v3.3.4' added and the previous 'Revision: v3.3.3' removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a Locations section with a Texas entry and removed the Texas Locations header. Also removed the HHS Vulnerability Disclosure link and updated the revision to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to SBRT and Virus Therapy Before Pembrolizumab in Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT and Virus Therapy Before Pembrolizumab in Cancer Clinical Trial page.